A Multimodal Approach to Intra-arterial Occlusion With Calcium Hydroxylapatite

Affiliations

Comment

Nina Hartman et al. Dermatol Surg. 2023.

. 2023 Feb 1;49(2):218-220.

doi: 10.1097/DSS.0000000000003667. Epub 2022 Dec 6.

No abstract available

Comment on

Managing intravascular complications following treatment with calcium hydroxylapatite: An expert consensus.
van Loghem J, Funt D, Pavicic T, Goldie K, Yutskovskaya Y, Fabi S, Siebenga P, Thuis J, Hkeik J, Kadouch J, Prager W, Azib N, Casabona G, Dayan S, Bay Aguilera S, Snozzi P, Saeed P. van Loghem J, et al. J Cosmet Dermatol. 2020 Nov;19(11):2845-2858. doi: 10.1111/jocd.13353. Epub 2020 Mar 17. J Cosmet Dermatol. 2020. PMID: 32185876 Free PMC article.

1. Rayess HM, Svider PF, Hanba C, Patel VS, et al. A cross-sectional analysis of adverse events and litigation for injectable fillers. JAMA Facial Plast Surg 2018;20:207–14.
1. Loghem J, Funt D, Pavicic T, Goldie K, et al. Managing intravascular complications following treatment with calcium hydroxylapatite: an expert consensus. J Cosmet Dermatol 2020;19:2845–58.
1. Darling MD, Peterson JD, Fabi SG. Impending necrosis after injection of hyaluronic acid and calcium hydroxylapatite fillers: report of 2 cases treated with hyperbaric oxygen therapy. Dermatol Surg 2014;40:1049–52.
1. Danysz W, Nowag B, Hengl T, Kreymerman P, et al. Can sodium thiosulfate act as a reversal agent for calcium hydroxylapatite filler? Results of a preclinical study. Clin Cosmet Investig Dermatol 2020;13:1059–73.
1. Yankova M, Pavicic T, Frank K, Schenck TL, et al. Intraarterial degradation of calcium hydroxylapatite using sodium thiosulfate - an in vitro and cadaveric study. Aesthet Surg J 2021;41:NP226–NP236.